SAFC Expands Irvine Facility
PTSM: Pharmaceutical Technology Sourcing and Management
The new facility will feature dry powder cell-culture media capabilities.
SAFC Commercial, a branch of the Sigma-Aldrich Corporation, recently announced they are expanding their facility capabilities to provide redundancy to the dry powder manufacturing supply chain. The dry-powder milling and blending for cell-culture media that occurs at the Lenexa, Kansas facility will also occur in the Irvine, Scotland locations. Liquid cell-culture media, buffers, and reagents are already prepared at the Irvine site.
According to a press release, the facility expansion will allow SAFC to create shorter lead times, increase storage capacity for finished goods, and support projects from “early clinical development through commercial scale using a globally consistent approach across all cell culture media manufacturing sites,” said Gilles Cottier, president of SAFC.
Source:
PR Newswire
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
